SPINK5, whose expression is reduced at both mRNA and protein levels in esophageal cancer and associated with tumor progression, has been suggested as a potential biomarker (81), although its role in colitis and CRC remains unclear. This evidence concerns the gene SPINK5 and colorectal carcinoma.